Skip to main content

Advertisement

SpringerLink
Log in

Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Since several studies have inconsistently reported the association between the use of selective serotonin reuptake inhibitors (SSRIs) and the risk of stroke, we performed a meta-analysis on this issue. We identified studies by searching three electronic databases (MEDLINE, EMBASE, and the Cochrane Library) from their inception to August, 2013. Pooled effect estimates were obtained by using random-effects meta-analysis. Thirteen relevant studies (three case–control, six nested case–control, and four cohort studies) were finally included in our study. In our meta-analyses, the use of SSRIs was associated with an increased risk of all types of stroke [adjusted odds ratio (aOR), 1.40; 95 % confidence interval (CI), 1.09–1.80], ischemic stroke (aOR 1.48; 95 % CI 1.08–2.02), and hemorrhagic stroke (aOR 1.32; 95 % CI 1.02–1.71). Between the two subtypes of hemorrhagic stroke, that is, intracerebral and subarachnoid, the increased risk of intracerebral hemorrhage was associated with the use of SSRIs (aOR 1.30; 95 % CI 1.02–1.67). When the analysis was restricted to the studies in which potential confounding by depression was considered, the risks were still higher in SSRI users than in non-users and the heterogeneities among studies were significantly decreased. Since there was heterogeneity among studies and a possible confounding effect from depression could not be fully excluded, further well-designed studies are needed to confirm this association.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR et al (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289:3095–3105

    Article  PubMed  Google Scholar 

  2. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB (2011) Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 306:1241–1249

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. de Abajo FJ, Rodriguez LA, Montero D (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319:1106–1109

    Article  PubMed Central  PubMed  Google Scholar 

  4. Skop BP, Brown TM (1996) Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors. Psychosomatics 37:12–16

    Article  CAS  PubMed  Google Scholar 

  5. Hung CC, Lin CH, Lan TH, Chan CH (2013) The association of selective serotonin reuptake inhibitors use and stroke in geriatric population. Am J Geriatr Psychiatry 21:811–815

    Article  PubMed  Google Scholar 

  6. Singhal AB, Caviness VS, Begleiter AF, Mark EJ, Rordorf G, Koroshetz WJ (2002) Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 58:130–133

    Article  CAS  PubMed  Google Scholar 

  7. Trifiro G, Dieleman J, Sen EF, Gambassi G, Sturkenboom MC (2010) Risk of ischemic stroke associated with antidepressant drug use in elderly persons. J Clin Psychopharmacol 30:252–258

    Article  CAS  PubMed  Google Scholar 

  8. Hackam DG, Mrkobrada M (2012) Selective serotonin reuptake inhibitors and brain hemorrhage: a meta-analysis. Neurology 79:1862–1865

    Article  CAS  PubMed  Google Scholar 

  9. Wells G, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa(ON) Ottawa Hospital Research Institute; Available: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (Accessed Aug 2013)

  10. Bak S, Tsiropoulos I, Kjaersgaard JO, Andersen M, Mellerup E, Hallas J et al (2002) Selective serotonin reuptake inhibitors and the risk of stroke: a population-based case-control study. Stroke 33:1465–1473

    Article  CAS  PubMed  Google Scholar 

  11. Chen Y, Guo JJ, Li H, Wulsin L, Patel NC (2008) Risk of cerebrovascular events associated with antidepressant use in patients with depression: a population-based, nested case-control study. Ann Pharmacother 42:177–184

    Article  PubMed  Google Scholar 

  12. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:d4551. doi:10.1136/bmj.d4551

    Article  PubMed Central  PubMed  Google Scholar 

  13. Pan A, Okereke OI, Sun Q, Logroscino G, Manson JE, Willett WC et al (2011) Depression and incident stroke in women. Stroke 42:2770–2775

    Article  PubMed Central  PubMed  Google Scholar 

  14. Smoller JW, Allison M, Cochrane BB, Curb JD, Perlis RH, Robinson JG et al (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women’s Health Initiative study. Arch Intern Med 169:2128–2139

    Article  PubMed  Google Scholar 

  15. Douglas I, Smeeth L, Irvine D (2011) The use of antidepressants and the risk of haemorrhagic stroke: a nested case control study. Br J Clin Pharmacol 71:116–120

    Article  PubMed Central  PubMed  Google Scholar 

  16. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560

    Article  PubMed Central  PubMed  Google Scholar 

  17. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  CAS  PubMed  Google Scholar 

  18. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Behr S, Andersohn F, Garbe E (2010) Risk of intracerebral hemorrhage associated with phenprocoumon exposure: a nested case-control study in a large population-based German database. Pharmacoepidemiol Drug Saf 19:722–730

    Article  PubMed  Google Scholar 

  20. de Abajo FJ, Jick H, Derby L, Jick S, Schmitz S (2000) Intracranial haemorrhage and use of selective serotonin reuptake inhibitors. Br J Clin Pharmacol 50:43–47

    Article  PubMed Central  PubMed  Google Scholar 

  21. Kharofa J, Sekar P, Haverbusch M, Moomaw C, Flaherty M, Kissela B et al (2007) Selective serotonin reuptake inhibitors and risk of hemorrhagic stroke. Stroke 38:3049–3051

    Article  CAS  PubMed  Google Scholar 

  22. Risselada R, Straatman H, van Kooten F, Dippel DW, van der Lugt A, Niessen WJ et al (2009) Withdrawal of statins and risk of subarachnoid hemorrhage. Stroke 40:2887–2892

    Article  CAS  PubMed  Google Scholar 

  23. Schalekamp T, Klungel OH, Souverein PC, De Boer A (2008) Increased bleeding risk with concurrent use of selective serotonin reuptake inhibitors and coumarins. Arch Intern Med 168:180–185

    Article  PubMed  Google Scholar 

  24. Verdel BM, Souverein PC, Meenks SD, Heerdink ER, Leufkens HGM, Egberts TCG (2011) Use of serotonergic drugs and the risk of bleeding. Clin Pharmacol Ther 89:89–96

    Article  CAS  PubMed  Google Scholar 

  25. Hauta-Aho M, Tirkkonen T, Vahlberg T, Laine K (2009) The effect of drug interactions on bleeding risk associated with warfarin therapy in hospitalized patients. Ann Med 41:619–628

    Article  CAS  PubMed  Google Scholar 

  26. Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V (2009) Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 8:355–369

    Article  PubMed  Google Scholar 

  27. Olfson MMSC (2009) NAtional patterns in antidepressant medication treatment. Arch Gen Psychiatry 66:848–856

    Article  PubMed  Google Scholar 

  28. Jakovljevic D, Tuomilehto J (2002) Use of selective serotonin reuptake inhibitors and the risk of stroke: is there reason for concern? Stroke 33:1448–1449

    Article  PubMed  Google Scholar 

  29. Muhonen MG, Robertson SC, Gerdes JS, Loftus CM (1997) Effects of serotonin on cerebral circulation after middle cerebral artery occlusion. J Neurosurg 87:301–306

    Article  CAS  PubMed  Google Scholar 

  30. Wu CS, Wang SC, Cheng YC, Gau SS (2011) Association of cerebrovascular events with antidepressant use: a case-crossover study. Am J Psychiatry 168:511–521

    Article  PubMed  Google Scholar 

  31. Robinson RG, Spalletta G (2010) Poststroke depression: a review. Can J Psychiatry 55:341–349

    PubMed Central  PubMed  Google Scholar 

  32. Chollet F, Tardy J, Albucher JF, Thalamas C, Berard E, Lamy C et al (2011) Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 10:123–130

    Article  CAS  PubMed  Google Scholar 

  33. Mikami K, Jorge RE, Adams HP Jr, Davis PH, Leira EC, Jang M et al (2011) Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry 19:1007–1015

    Article  PubMed Central  PubMed  Google Scholar 

  34. Jorge RE, Acion L, Moser D, Adams HP Jr, Robinson RG (2010) Escitalopram and enhancement of cognitive recovery following stroke. Arch Gen Psychiatry 67:187–196

    Article  PubMed Central  PubMed  Google Scholar 

  35. Mortensen JK, Larsson H, Johnsen SP, Andersen G (2013) Post stroke use of selective serotonin reuptake inhibitors and clinical outcome among patients with ischemic stroke: a nationwide propensity score-matched follow-up study. Stroke 44:420–426

    Article  CAS  PubMed  Google Scholar 

  36. Stegmayr B, Vinogradova T, Malyutina S, Peltonen M, Nikitin Y, Asplund K (2000) Widening gap of stroke between east and west. Eight-year trends in occurrence and risk factors in Russia and Sweden. Stroke 31:2–8

    Article  CAS  PubMed  Google Scholar 

  37. Kinlay S (2011) Changes in stroke epidemiology, prevention, and treatment. Circulation 124:e494–e496

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by Grant from the Seoul National University Hospital Research Fund, No. 2320130020 (2013–2439) and National Research Foundation of Korea (NRF) Grant funded by the Korean Government (Grant No. 2013R1A1A1A05004957).

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Department of Family Medicine, Seoul National University College of Medicine, 28 Yunkeon-dong, Jongro-gu, Seoul, 110-744, South Korea

    Doosup Shin, Yun Hwan Oh & Sang Min Park

  2. Jangseong Public Health Center, Jangseong, South Korea

    Doosup Shin

  3. Department of Family Medicine, Hallym University Chuncheon Sacred Heart Hospital, Chuncheon, Korea

    Chun-Sick Eom

  4. Department of Biomedical Sciences, Seoul National University College of Medicine, 28 Yunkeon-dong, Jongro-gu, Seoul, 110-744, South Korea

    Sang Min Park

Authors
  1. Doosup Shin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yun Hwan Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Chun-Sick Eom
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sang Min Park
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sang Min Park.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 39 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shin, D., Oh, Y.H., Eom, CS. et al. Use of selective serotonin reuptake inhibitors and risk of stroke: a systematic review and meta-analysis. J Neurol 261, 686–695 (2014). https://doi.org/10.1007/s00415-014-7251-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-014-7251-9

Keywords

Search

Navigation